alternatives to tirzepatide for patients intolerant Semaglutide vs Tirzepatide: Complete Comparison (2026) GLP-1 Genetics: How Genes Affect

Note: Retatrutide is not currently FDA approved for human use, and purchases should be for research only unless prescribed by a qualified healthcare provider

Understanding the full spectrum of available optionsincluding branded and compounded formulationshelps patients and providers make informed decisions aligned with clinical evidence and individual health profiles

Disclosures: None Show notes 1

Compounded GLP-1 scripts arent directly tracked, but public disclosures let us triangulate a credible range

After completing baseline assessment, both subject groups engaged in resistance training for 8 weeks, with follow-up measures conducted at the conclusion of the eighth week